Cargando…
VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs
Lyme disease, a public health threat of significance to both veterinary and human medicine, is caused by the tick (Ixodes) transmitted spirochete, Borreliella burgdorferi. Here we report on the immunogenicity and efficacy of VANGUARD®crLyme (Zoetis), the most recent canine Lyme disease vaccine to be...
Autores principales: | Marconi, Richard T., Garcia-Tapia, David, Hoevers, Jacquelien, Honsberger, Nicole, King, Vickie L., Ritter, Dianne, Schwahn, Denise J., Swearingin, Leroy, Weber, Angela, Winkler, M. Teresa C., Millership, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733144/ https://www.ncbi.nlm.nih.gov/pubmed/33336185 http://dx.doi.org/10.1016/j.jvacx.2020.100079 |
Ejemplares similares
-
Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogs
por: Marconi, Richard T., et al.
Publicado: (2020) -
Borrelia burgdorferi (Lyme Disease)
por: Shapiro, Eugene D.
Publicado: (2014) -
Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes
por: Cabello, Felipe C., et al.
Publicado: (2022) -
Population Dynamics of Borrelia burgdorferi in Lyme Disease
por: Binder, Sebastian C., et al.
Publicado: (2012) -
Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs
por: Wagner, Bettina, et al.
Publicado: (2015)